| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_669fbe41bc471976b465c9753ed286fb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 |
| filingDate |
2021-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_658a6905f803a1fedfe59e04cd90e057
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86463f589f0f93d4b499ff53e88438ae |
| publicationDate |
2021-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021235527-A1 |
| titleOfInvention |
Liquid preparation containing brimonidine |
| abstract |
The purpose of the present invention is to provide a liquid preparation for ophthalmic use which comprises brimonidine or a salt thereof. On the basis of the finding that a liquid preparation for ophthalmic use, which contains brimonidine at a low concentration and to which chondroitin sulfate and/or a salt thereof are added, has good transferability to the conjunctival tissue and shows reduced cytotoxicity caused by brimonidine, provided is a liquid preparation for ophthalmic use which contains brimonidine at a low concentration and chondroitin sulfate and/or a salt thereof. |
| priorityDate |
2020-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |